NKH477 | CAS#138605-00-2

NKH477
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 532351

CAS#: 138605-00-2

Description: NKH477 is a potent activator of adenylyl cyclase. NKH477 shows some selectivity for cardiac (type V) adenylyl cyclase. NKH477 stimulates bronchodilation (EC50 = 32.6 nM) and is an orally active potent positive chronotrope and hypotensive agent in vivo.

Chemical Structure

NKH477

CAS# 138605-00-2

Product data Instruction

Theoretical Analysis

MedKoo Cat#: 532351
Name: NKH477
CAS#: 138605-00-2
Chemical Formula: C28H45ClO8
Exact Mass: 544.28
Molecular Weight: 545.110
Elemental Analysis: C, 61.70; H, 8.32; Cl, 6.50; O, 23.48

Price and Availability

Size	Price	Availability	Quantity
5mg	USD 230
10mg	USD 360
Bulk inquiry Welcome, Customer: Please do not inquire quote if your intended use is for a patient since our products are for research use and for chemical synthesis use, not for human use . For in-stock products, we listed price in the web page. You may inquire prices for which sizes were not listed. If no price is listed, this means the product is not in stock at the moment, which may be available via custom synthesis. For cost-effective reason, minimum order of 1g is requested (typically very expensive). The lead time is usually 2-4 months. Quote of less than 1g will not be provided. MedKoo may not offer quote for below reasons: (1) current available synthetic method appears to be extremely expensive which is obviously not affordable to most customers; (2) Key raw material to make the product is temporally not available; (3) DEA controlled substances; (4) the product is under patent protection in customer’s country.

Synonym: NKH477; NKH 477; NKH-477.

IUPAC/Chemical Name: (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-5-(acetyloxy)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-dodecahydro-1H-naphtho[2,1-b]pyran-6-yl 4-methylpentanoate hydrochloride

InChi Key: LNEICJSEZPSKSJ-RPBMHHKSSA-N

InChi Code: InChI=1S/C28H44O8.ClH/c1-10-25(7)15-19(31)28(33)26(8)18(30)13-14-24(5,6)22(26)21(35-20(32)12-11-16(2)3)23(34-17(4)29)27(28,9)36-25;/h10,16,18,21-23,30,33H,1,11-15H2,2-9H3;1H/t18-,21-,22-,23-,25-,26-,27+,28-;/m0./s1

SMILES Code: CC(C)CCC(O[C@@H]([C@@]1([H])C(C)(C)CC[C@H](O)[C@@]12C)[C@H](OC(C)=O)[C@]3(C)[C@]2(O)C(C[C@](C)(C=C)O3)=O)=O.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Product Data:

Product Data

Instruction:

View handling instruction

Biological target:	NKH477 (Colforsin dapropate hydrochloride) directly activates the catalytic unit of adenylate cyclase.
In vitro activity:	NKH477 is a direct adenylate cyclase activator derived from forskolin and now under clinical investigation as a positive inotropic agent. Addition of NKH477 to the culture medium suppressed the generation of CTL, T cell proliferation in MLR, and production of IL-2 in MLR and in mitogen response. Reference: Clin Immunol Immunopathol. 1996 Apr;79(1):25-35. https://pubmed.ncbi.nlm.nih.gov/8612348/
In vivo activity:	Left lungs were transplanted orthotopically from Brown-Norway donors to Lewis recipients. Recipient rats were untreated or treated daily with different doses of NKH477. NKH477 significantly extended allograft survival time in a dose-dependent manner and reduced histopathological rejection. Treatment with NKH477 inhibited IFN-gamma and IL-10 expression, whereas expression of these cytokines were markedly upregulated in the untreated allografts. Reference: J Heart Lung Transplant. 2005 Apr;24(4):462-9. https://pubmed.ncbi.nlm.nih.gov/15797749/

Solubility Data

	Solvent	Max Conc. mg/mL	Max Conc. mM
Solubility
	DMF	20.0	36.69
	DMSO	77.5	142.17
	DMSO:PBS (pH 7.2) (1:1)	0.5	0.92
	Ethanol	2.5	4.59
	Water	20.9	38.38

Preparing Stock Solutions

The following data is based on the product molecular weight 545.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:	1. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol. 1996 Apr;79(1):25-35. doi: 10.1006/clin.1996.0047. PMID: 8612348. 2. Ito S, Suzuki S, Itoh T. Effects of a water-soluble forskolin derivative (NKH477) and a membrane-permeable cyclic AMP analogue on noradrenaline-induced Ca2+ mobilization in smooth muscle of rabbit mesenteric artery. Br J Pharmacol. 1993 Nov;110(3):1117-25. doi: 10.1111/j.1476-5381.1993.tb13930.x. PMID: 8298800; PMCID: PMC2175778. 3. Nakashima S, Morikawa M, Komatsu K, Matsuura A, Sato N, Abe T. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts. J Heart Lung Transplant. 2005 Apr;24(4):462-9. doi: 10.1016/j.healun.2004.02.011. PMID: 15797749. 4. Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Tatee T, Nakamura K. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol. 1992 Apr;19(4):625-34. doi: 10.1097/00005344-199204000-00021. PMID: 1380607.
In vitro protocol:	1. Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol. 1996 Apr;79(1):25-35. doi: 10.1006/clin.1996.0047. PMID: 8612348. 2. Ito S, Suzuki S, Itoh T. Effects of a water-soluble forskolin derivative (NKH477) and a membrane-permeable cyclic AMP analogue on noradrenaline-induced Ca2+ mobilization in smooth muscle of rabbit mesenteric artery. Br J Pharmacol. 1993 Nov;110(3):1117-25. doi: 10.1111/j.1476-5381.1993.tb13930.x. PMID: 8298800; PMCID: PMC2175778.
In vivo protocol:	1. Nakashima S, Morikawa M, Komatsu K, Matsuura A, Sato N, Abe T. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts. J Heart Lung Transplant. 2005 Apr;24(4):462-9. doi: 10.1016/j.healun.2004.02.011. PMID: 15797749. 2. Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Tatee T, Nakamura K. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol. 1992 Apr;19(4):625-34. doi: 10.1097/00005344-199204000-00021. PMID: 1380607.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

Mass

Concentration

Volume

M. Wt* g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Dilution Calculator

Calculate the dilution required to prepare a stock solution.

Concentration 1

Volume 1

Concentration 2

Volume 2

1: Nakashima S, Morikawa M, Komatsu K, Matsuura A, Sato N, Abe T. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts. J Heart Lung Transplant. 2005 Apr;24(4):462-9. PubMed PMID: 15797749.

2: Morikawa M, Nakashima S, Komatsu K, Abe T. NKH477, a forskolin derivative, exerts an antiproliferative effect in vivo with an altered cytokine profile in rat recipients of orthotopic lung allografts. J Heart Lung Transplant. 2001 Feb;20(2):254. PubMed PMID: 11250507.

3: Hara S, Tanahashi M, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S. Effects of NKH477 on endothelin-1-induced renal responses in anaesthetized dogs. Clin Exp Pharmacol Physiol. 2000 Jul;27(7):513-5. PubMed PMID: 10874508.

4: Tanahashi M, Hara S, Saitoh K, Yoshida M, Suzuki-Kusaba M, Hisa H, Satoh S. Effects of NKH477 on renal nerve stimulation-induced responses in anesthetized dogs. Eur J Pharmacol. 1999 Nov 12;384(1):31-6. PubMed PMID: 10611416.

5: Tanahashi M, Hara S, Yoshida M, Suzuki-Kusaba M, Yokoyama H, Hosono M, Hisa H, Satoh S. Effects of NKH477 on renal functions and cyclic AMP production in anesthetized dogs. Eur J Pharmacol. 1999 May 21;372(3):253-9. PubMed PMID: 10395020.

6: Morinobu S, Fujimaki K, Okuyama N, Takahashi M, Duman RS. Stimulation of adenylyl cyclase and induction of brain-derived neurotrophic factor and TrkB mRNA by NKH477, a novel and potent forskolin derivative. J Neurochem. 1999 May;72(5):2198-205. PubMed PMID: 10217303.

7: Satake K, Takagi K, Kodama I, Honjo H, Toyama J, Shibata S. Relaxant effects of NKH477, a new water-soluble forskolin derivative, on guinea-pig tracheal smooth muscle: the role of Ca2+-activated K+ channels. Br J Pharmacol. 1998 Feb;123(4):753-61. PubMed PMID: 9517396; PubMed Central PMCID: PMC1565213.

8: Koshika T, Nagayama T, Iizuka Y, Kimura T, Satoh S. Effects of NKH477, a forskolin derivative, and dibutyryl-cyclic AMP on adrenal catecholamine release in response to splanchnic nerve stimulation, acetylcholine, DMPP and muscarine in anesthetized dogs. Fundam Clin Pharmacol. 1997;11(6):512-8. PubMed PMID: 9444518.

9: Maeda H, Ozawa H, Saito T, Irie T, Takahata N. Potential antidepressant properties of forskolin and a novel water-soluble forskolin (NKH477) in the forced swimming test. Life Sci. 1997;61(25):2435-42. PubMed PMID: 9416762.

10: Ishizuka O, Fujita A, Kanbe E, Noguchi M, Hosono M, Sakitama K. [Effectiveness of NKH477, a novel forskolin derivative, in rat cardiac preparations with desensitized beta-adrenoceptors]. Nihon Yakurigaku Zasshi. 1996 Jul;108(1):23-30. Japanese. PubMed PMID: 8810493.

11: Furukawa Y, Matsumori A, Hirozane T, Matsui S, Sato Y, Ono K, Sasayama S. Immunomodulation by an adenylate cyclase activator, NKH477, in vivo and vitro. Clin Immunol Immunopathol. 1996 Apr;79(1):25-35. PubMed PMID: 8612348.

12: Sanbe A, Takeo S. Effects of NKH477, a water-soluble forskolin derivative, on cardiac function in rats with chronic heart failure after myocardial infarction. J Pharmacol Exp Ther. 1995 Jul;274(1):120-6. Erratum in: J Pharmacol Exp Ther 1996 Jan;276(1):352. PubMed PMID: 7616388.

13: Iida M, Fujita N, Hosono M, Sukenaga Y. Bronchodilator and cardiovascular effects of NKH477, a novel water-soluble forskolin derivative, in guinea pigs. Jpn J Pharmacol. 1995 Jul;68(3):245-53. PubMed PMID: 7474547.

14: Mori M, Takeuchi M, Takaoka H, Hata K, Hayashi Y, Yokoyama M. Effect of NKH477, a new water-soluble forskolin derivative, on arterial-ventricular coupling and mechanical energy transduction in patients with left ventricular systolic dysfunction: comparison with dobutamine. J Cardiovasc Pharmacol. 1994 Aug;24(2):310-6. PubMed PMID: 7526066.

15: Hirasawa A, Awaji T, Hosono M, Haruno A, Hashimoto K. Effects of a new forskolin derivative, NKH477, on canine ventricular arrhythmia models. J Cardiovasc Pharmacol. 1993 Dec;22(6):847-51. PubMed PMID: 7509903.

16: Ito S, Suzuki S, Itoh T. Effects of a water-soluble forskolin derivative (NKH477) and a membrane-permeable cyclic AMP analogue on noradrenaline-induced Ca2+ mobilization in smooth muscle of rabbit mesenteric artery. Br J Pharmacol. 1993 Nov;110(3):1117-25. PubMed PMID: 8298800; PubMed Central PMCID: PMC2175778.

17: Ishizuka O, Hosono M, Nakamura K. Profile of cardiovascular effects of NKH477, a novel forskolin derivative, assessed in isolated, blood-perfused dog heart preparations: comparison with isoproterenol. J Cardiovasc Pharmacol. 1992 Aug;20(2):261-7. PubMed PMID: 1381017.

18: Shafiq J, Suzuki S, Itoh T, Kuriyama H. Mechanisms of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. Circ Res. 1992 Jul;71(1):70-81. PubMed PMID: 1318797.

19: Fujita A, Takahira T, Hosono M, Nakamura K. Improvement of drug-induced cardiac failure by NKH477, a novel forskolin derivative, in the dog heart-lung preparation. Jpn J Pharmacol. 1992 Apr;58(4):375-81. PubMed PMID: 1405034.

20: Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Tatee T, Nakamura K. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol. 1992 Apr;19(4):625-34. PubMed PMID: 1380607.

Your view history

NKH477 featured